Entrada announces development of ENTR-501 for mitochondrial neurogastrointestinal encephalomyopathy Jan. 10, 2020
Biallelic loss-of-function variants in NADSYN1 cause congenital NAD deficiency and malformations Jan. 10, 2020
Redx Pharma nominates ROCK2 inhibitor RXC-007 as drug development candidate in fibrosis Jan. 10, 2020
RSS